← FDA DRUG APPROVALS

FDA ANDA · ANDA074203

ATENOLOL AND CHLORTHALIDONE

Sponsor: AUROBINDO PHARMA USA

APPLICATION
ANDA074203
TYPE
ANDA
ORIGINAL APPROVAL
1993-10-31
LATEST ACTION
2015-07-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ATENOLOL AND CHLORTHALIDONEDiscontinued
ATENOLOL 100MG, CHLORTHALIDONE 25MG · TABLET · ORAL
ATENOLOL AND CHLORTHALIDONEDiscontinued
ATENOLOL 50MG, CHLORTHALIDONE 25MG · TABLET · ORAL

Approval history

2015-07-31Labeling · Supplement 23 · standardAP
2009-03-20Labeling · Supplement 18AP
2005-12-12Labeling · Supplement 11AP
2004-02-06Labeling · Supplement 10AP
2003-10-22Labeling · Supplement 9AP
2002-08-22Manufacturing (CMC) · Supplement 8AP
2000-08-14Labeling · Supplement 7AP
2000-06-07Labeling · Supplement 6AP
1998-12-28Manufacturing (CMC) · Supplement 5AP
1998-02-05Manufacturing (CMC) · Supplement 4AP
1997-03-03Labeling · Supplement 3AP
1996-09-18Manufacturing (CMC) · Supplement 2AP
1994-08-31Labeling · Supplement 1AP
1993-10-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →